Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores

Int J Urol. 2023 Nov;30(11):1054-1056. doi: 10.1111/iju.15249. Epub 2023 Jul 11.

Authors

Tomokazu Sazuka¹, Takayuki Arai¹, Hiroaki Sato¹, Yusuke Goto¹, Shinichi Sakamoto¹, Tomohiko Ichikawa¹

Affiliation

¹ Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.

PMID: 37431967
DOI: 10.1111/iju.15249

No abstract available

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Humans
Kidney Neoplasms* / pathology
Nivolumab / therapeutic use
Retrospective Studies

Substances

Nivolumab

Grants and funding

22K09494/KAKENHI